Journal of Immunotherapy and Precision Oncology : Impact Factor & More
eISSN: 2590-017XpISSN: 2666-2345
Open AccessShare this on:
Key Metrics
CiteScore 
1.8
H-Index
7
SJR
Q3Oncology
SNIP
0.29
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology Journal Specifications
| Overview | |
| Publisher | Innovative Healthcare Institute |
| Language | English |
| Article Processing Charges | USD 2400 |
| Publication Time | 24 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND, Public domain |
| OA statement | Visit website |
View less
Planning to publish in Journal of Immunotherapy and Precision Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of Immunotherapy and Precision Oncology
Abstracts for the 2026 Immunotherapy and Precision Oncology Forum: April 11, 2026, Cincinnati, OH, USA.
- 10 Apr 2026
- Journal of immunotherapy and precision oncology
Abstracts Presented at the 2026 Precision Oncology Saudi Summit: February 12-14, 2026, Madinah, Saudi Arabia.
- 1 Apr 2026
- Journal of immunotherapy and precision oncology
Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond.
- 1 Apr 2026
- Journal of immunotherapy and precision oncology
Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies
- 16 Mar 2026
- Journal of Immunotherapy and Precision Oncology
Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer.
- 10 Feb 2026
- Journal of immunotherapy and precision oncology
AXL Inhibitors in Oncology Clinical Trials: A Review
- 3 Dec 2025
- Journal of Immunotherapy and Precision Oncology
Abstracts for the 2026 Immunotherapy and Precision Oncology Forum: April 11, 2026, Cincinnati, OH, USA.
- 10 Apr 2026
- Journal of immunotherapy and precision oncology
Abstracts Presented at the 2026 Precision Oncology Saudi Summit: February 12-14, 2026, Madinah, Saudi Arabia.
- 1 Apr 2026
- Journal of immunotherapy and precision oncology
Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond.
- 1 Apr 2026
- Journal of immunotherapy and precision oncology
Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies
- 16 Mar 2026
- Journal of Immunotherapy and Precision Oncology
Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer.
- 10 Feb 2026
- Journal of immunotherapy and precision oncology
AXL Inhibitors in Oncology Clinical Trials: A Review
- 3 Dec 2025
- Journal of Immunotherapy and Precision Oncology
FAQs on Journal of Immunotherapy and Precision Oncology
How many articles did Journal of Immunotherapy and Precision Oncology publish last year? 
What is the eISSN & pISSN for Journal of Immunotherapy and Precision Oncology?
What is Citescore for Journal of Immunotherapy and Precision Oncology?
What is the H Index for Journal of Immunotherapy and Precision Oncology ?
What is SNIP score for Journal of Immunotherapy and Precision Oncology?
What is the SJR for Journal of Immunotherapy and Precision Oncology?
Who is the publisher of Journal of Immunotherapy and Precision Oncology?
